Natera News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.10.24	Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis (RTTNews)
23.08.24	Natera - Harkening Back To Its Heyday (RTTNews)
05.04.24	Natera Announces Positive Results From IMvigor011 Phase III Study In Muscle-Invasive Bladder Cancer (RTTNews)
27.02.24	Natera Seeks Royalty For AlloSure Tests From CareDx In Patent Infringement Case (RTTNews)
29.01.24	CareDx Announces Mixed Jury Verdict In Patent Litigation Against Natera (RTTNews)
22.01.24	Natera Acquires Assets From Invitae (RTTNews)
09.01.24	Natera Preliminary Q4 Revenues Up Approx. 38% YoY - Quick Facts (RTTNews)
14.11.23	Natera Signs Real-World Data Collaboration With Merck (RTTNews)
07.09.23	Natera Prices Follow-On Offering At $55/share, Totaling $250 Mln (RTTNews)
09.03.23	These 5 Biotech Stocks Could Have Earned You Big Bucks (RTTNews)
16.02.23	Natera Rallies As Medicare Extends Coverage Of Signatera Test For Breast Cancer (RTTNews)
16.11.22	Natera Prices 11.43 Mln Shares At $35/shr (RTTNews)
08.11.22	Natera Reports Third Quarter 2022 Financial Results (PR Newswire)
01.11.22	Natera to Report its Third Quarter 2022 Results on November 8th (PR Newswire)
29.09.22	Natera Announces 2025 ESG Goals with Publication of 2021 Report (PR Newswire)
10.08.22	Natera Announces Q-Sub Filing with FDA for its Panorama® NIPT (PR Newswire)
04.08.22	Natera Reports Second Quarter 2022 Financial Results (PR Newswire)
01.08.22	Natera Announces Second Quarter 2022 Earnings Conference Call (PR Newswire)
26.06.22	NTRA FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important June 27 Deadline in Securities Class Action - NTRA (PR Newswire)
15.06.22	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Natera, Inc. Investors to Secure Counsel Before Important June 27 Deadline in Securities Class Action - NTRA (PR Newswire)
07.06.22	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Natera, Inc. Investors With Losses Over $100K to Secure Counsel Before Important June 27 Deadline in Securities Class Action - NTRA (PR Newswire)
26.05.22	NATERA, INC. Company News: Berger Montague Investigates Securities Fraud Allegations Against Natera, Inc. (NASDAQ: NTRA); Lead Plaintiff Deadline is June 27, 2022 (PR Newswire)
22.05.22	ROSEN, A LEADING LAW FIRM, Encourages Natera, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTRA (PR Newswire)
16.05.22	Matthew Rabinowitz, Natera Co-Founder and Executive Chairman of the Board, Makes Additional Investment in Natera (PR Newswire)
15.05.22	ROSEN, LEADING INVESTOR COUNSEL, Encourages Natera, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NTRA (PR Newswire)
07.05.22	ROSEN, A TOP RANKED LAW FIRM, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NTRA (PR Newswire)
05.05.22	Natera Reports First Quarter 2022 Financial Results (PR Newswire)
15.03.22	Jury Finds CareDx and Natera Engaged in False Advertising (PR Newswire)
14.03.22	Natera To Pay Salaries Of Top Executives In Stock For Remainder Of 2022 (RTTNews)
10.03.22	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Natera, Inc. Investors with Losses to Inquire About Class Action Investigation - NTRA (PR Newswire)
09.03.22	NATERA RESPONDS TO MISLEADING SHORT SELLER REPORT (PR Newswire)
24.02.22	Natera Reports Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
23.01.22	Study Shows Natera's Signatera MRD Test Predictive Of Chemotherapy Benefit In Colorectal Cancer (RTTNews)
22.01.22	Landmark CIRCULATE-Japan Study Shows Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer (PR Newswire)
19.11.21	Natera's Panorama SMART Study Results Accepted for Publication by the American Journal of Obstetrics and Gynecology (AJOG) (PR Newswire)
11.11.21	Medicare Publishes Final Local Coverage Determination for Pan-Cancer Immunotherapy Monitoring with Natera's Signatera™ MRD Test (PR Newswire)
04.11.21	Natera Reports Third Quarter 2021 Financial Results (PR Newswire)
10.08.21	Natera to Participate in Upcoming Investor Conferences (PR Newswire)
05.08.21	Natera Reports Second Quarter 2021 Financial Results (PR Newswire)
04.08.21	Natera Announces Use of Signatera® as a Companion Diagnostic in GSK's Phase III ZEST Trial for Niraparib in Early-Stage Breast Cancer (PR Newswire)
29.07.21	Natera Announces Second Quarter 2021 Earnings Conference Call (PR Newswire)
28.07.21	New Study Validates the Signatera® MRD Test and Demonstrates its Clinical Utility in Early-Stage Esophageal Cancer (PR Newswire)
22.07.21	New Publication Shows 96% Overall Survival Among Metastatic Colorectal Cancer Patients Who Test MRD-Negative with Signatera® After Surgery (PR Newswire)
19.07.21	Natera Reports Preliminary Second Quarter 2021 Results (PR Newswire)
02.07.21	New Results From the Landmark Prospective CIRCULATE Trial Expand Clinical Utility of the Signatera® MRD Test in Colorectal Cancer (PR Newswire)
24.06.21	Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China (PR Newswire)
18.06.21	Natera Awarded Advanced Diagnostic Laboratory Test (ADLT) Status for its Signatera® MRD Test From CMS (PR Newswire)
16.06.21	Nature Journal Publishes Prospective, Randomized Study Validating Signatera® for Prediction of Immunotherapy Benefit (PR Newswire)
08.06.21	Foundation Medicine Launches FoundationOne®Tracker ctDNA Monitoring Assay for Research Use in Partnership with Natera (PR Newswire)
18.05.20	Natera, Illumina Settle Patent Dispute - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Natera Inc

Aktien Top/Flop

Meistgelesene Nachrichten